Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 2,593 | 1,858 | 1,719 | 3,049 | 22,146 |
| Gross Profit | 2,593 | 1,858 | 1,719 | 3,049 | 22,146 |
| Operating Expenses | 47,437 | 46,941 | 40,216 | 48,713 | 34,075 |
| Operating Income | -44,844 | -45,083 | -38,497 | -45,664 | -11,929 |
| Interest Expense | 180 | 180 | 153 | 2,563 | 93 |
| Other Income | 655 | 1 | -1,842 | 1,116 | 769 |
| Pre-tax Income | -44,369 | -45,262 | -40,492 | -47,111 | -11,253 |
| Income Tax | N/A | N/A | N/A | -54 | N/A |
| Net Income Continuous | -44,369 | -45,262 | -40,492 | -47,057 | -11,253 |
| Net Income | $-44,369 | $-45,262 | $-40,492 | $-47,057 | $-11,253 |
| EPS Basic Total Ops | -0.50 | -0.53 | -0.68 | -0.83 | -0.20 |
| EPS Basic Continuous Ops | -0.50 | -0.53 | -0.68 | -0.83 | -0.20 |
| EPS Diluted Total Ops | -0.50 | -0.53 | -0.68 | -0.83 | -0.20 |
| EPS Diluted Continuous Ops | -0.50 | -0.53 | -0.68 | -0.83 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.53 | -0.68 | -0.83 | -0.20 |
| EBITDA(a) | $-44,386 | $-44,603 | $-38,014 | $-45,445 | $-11,738 |